Are asylum seekers, refugees and foreign migrants considered in the COVID-19 vaccine discourse?

Type Journal Article Author Ferdinand C. Mukumbang URL https://gh.bmj.com/content/5/11/e004085 Rights © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. Volume 5 Issue 11 Pages e004085 Publication BMJ Global Health ISSN 2059-7908 Date 11/11/2020 Extra Publisher: BMJ Specialist Journals Section: Commentary PMID: 33177039 DOI 10.1136/bmjgh-2020-004085 Library Catalog gh.bmj.com Language en Abstract ### Summary box There is a propitious belief that a potent vaccine against the SARS-COV-2 virus is a panacea for the COVID-19 pandemic. The need for a potent vaccine is heightened as many nations are finding it counterproductive to sustain national lockdowns and individuals are becoming complacent with their hygiene and social (physical) distancing practices. Currently, there are more than 100 COVID-19 vaccine candidates under development, with a number of these in the human trial phase. It is suggested that the introduction of a COVID-19 vaccine will prevent the loss of US$375 billion to the global economy every month.1 There is a scientific consensus that the only way toeradicate the pandemic will be to vaccinate all people worldwide.2 To this end, the United Nations General Assembly calls …